CDC Delays COVID-19 Vaccine Study, Prompting Questions on Methodology and Transparency

A delayed CDC study highlights ongoing tensions around scientific processes and communication in public health. The report, intended for the Morbidity and Mortality Weekly Report (MMWR), found the 2025–26 COVID-19 vaccine reduced severe illness risk by 50% in adults.

Its postponement, tied to methodological concerns about a commonly used evaluation approach, has raised questions among current and former staff about transparency, timeliness, and trust.

For public health communicators, the situation underscores the importance of clearly explaining research methods, reinforcing evidence-based messaging, and maintaining public confidence amid evolving scientific and policy discussions. Read more from NBC News here.